No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
No Data
Amneal Pharmaceuticals to Develop Omalizumab Biosimilar for Allergy Treatments
Goldman Sachs Sticks to Their Buy Rating for Novartis AG (NOVN)
FDA Accepts Ionis' (IONS) NDA for Rare Disease Drug Olezarsen
Exsilio Therapeutics Launches With $82 Million Series A Financing to Develop Redosable Genomic Medicines for A Broad Range of Diseases
Contineum Therapeutics Announces Appointment of Sarah Boyce to Board of Directors
Nestle Carefully Targets Weight-Loss Drug Users With New Food Line